146 related articles for article (PubMed ID: 15010275)
41. Comparison of anti-aggregatory effects of PGI2, PGI3 and iloprost on human and rabbit platelets.
Kobzar G; Mardla V; Järving I; Samel N
Cell Physiol Biochem; 2001; 11(5):279-84. PubMed ID: 11684817
[TBL] [Abstract][Full Text] [Related]
42. VEGF expression is augmented by hypoxia‑induced PGIS in human fibroblasts.
Wang J; Ikeda R; Che XF; Ooyama A; Yamamoto M; Furukawa T; Hasui K; Zheng CL; Tajitsu Y; Oka T; Tabata S; Nishizawa Y; Eizuru Y; Akiyama S
Int J Oncol; 2013 Sep; 43(3):746-54. PubMed ID: 23807031
[TBL] [Abstract][Full Text] [Related]
43. Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture.
Kamio K; Sato T; Liu X; Sugiura H; Togo S; Kobayashi T; Kawasaki S; Wang X; Mao L; Ahn Y; Holz O; Magnussen H; Rennard SI
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1226-32. PubMed ID: 18424619
[TBL] [Abstract][Full Text] [Related]
44. Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis.
Peshavariya HM; Liu GS; Chang CW; Jiang F; Chan EC; Dusting GJ
Antioxid Redox Signal; 2014 Jun; 20(17):2710-25. PubMed ID: 24450852
[TBL] [Abstract][Full Text] [Related]
45. Prostacyclin protects vascular integrity via PPAR/14-3-3 pathway.
Chu LY; Liou JY; Wu KK
Prostaglandins Other Lipid Mediat; 2015; 118-119():19-27. PubMed ID: 25910681
[TBL] [Abstract][Full Text] [Related]
46. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
[TBL] [Abstract][Full Text] [Related]
47. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
Benyahia C; Boukais K; Gomez I; Silverstein A; Clapp L; Fabre A; Danel C; Leséche G; Longrois D; Norel X
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():48-55. PubMed ID: 23850788
[TBL] [Abstract][Full Text] [Related]
48. Mouse strain-dependent heterogeneity of resting limbal vasculature.
Chan CK; Pham LN; Chinn C; Spee C; Ryan SJ; Akhurst RJ; Hinton DR
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):441-7. PubMed ID: 14744883
[TBL] [Abstract][Full Text] [Related]
49. Targeted delivery of carbaprostacyclin to ischemic hindlimbs enhances adaptive remodeling of the microvascular network.
Liu X; Terry T; Pan S; Yang Z; Willerson JT; Dixon RA; Liu Q
Hypertension; 2013 May; 61(5):1036-43. PubMed ID: 23529172
[TBL] [Abstract][Full Text] [Related]
50. Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.
Nemenoff R; Meyer AM; Hudish TM; Mozer AB; Snee A; Narumiya S; Stearman RS; Winn RA; Weiser-Evans M; Geraci MW; Keith RL
Cancer Prev Res (Phila); 2008 Oct; 1(5):349-56. PubMed ID: 19138979
[TBL] [Abstract][Full Text] [Related]
51. Diverse effects of prostacyclin on angiogenesis-related processes in the porcine endometrium.
Szymanska M; Blitek A
Sci Rep; 2023 Aug; 13(1):14133. PubMed ID: 37644083
[TBL] [Abstract][Full Text] [Related]
52. Prostacyclin facilitates vascular smooth muscle cell phenotypic transformation via activating TP receptors when IP receptors are deficient.
Li Z; Luo W; Fang S; Chen X; Lin T; Zhou S; Zhang L; Yang W; Li Z; Ye J; Wang J; Liu P; Li Z
Acta Physiol (Oxf); 2021 Feb; 231(2):e13555. PubMed ID: 32886850
[TBL] [Abstract][Full Text] [Related]
53. Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low
Gatfield J; Menyhart K; Wanner D; Gnerre C; Monnier L; Morrison K; Hess P; Iglarz M; Clozel M; Nayler O
J Pharmacol Exp Ther; 2017 Jul; 362(1):186-199. PubMed ID: 28476928
[TBL] [Abstract][Full Text] [Related]
54. Induction of VEGF and its Flt-1 receptor after sciatic nerve crush injury.
Islamov RR; Chintalgattu V; Pak ES; Katwa LC; Murashov AK
Neuroreport; 2004 Sep; 15(13):2117-21. PubMed ID: 15486493
[TBL] [Abstract][Full Text] [Related]
55. The effect of iloprost on cell proliferation and angiogenesis-related gene expression in human periodontal ligament cells.
Jearanaiphaisarn T; Sanharati T; Pavasant P; Nakalekha Limjeerajarus C
Odontology; 2018 Jan; 106(1):11-18. PubMed ID: 28547570
[TBL] [Abstract][Full Text] [Related]
56. A novel pathway of prostacyclin signaling-hanging out with nuclear receptors.
Lim H; Dey SK
Endocrinology; 2002 Sep; 143(9):3207-10. PubMed ID: 12193530
[TBL] [Abstract][Full Text] [Related]
57. Structural basis for iloprost as a dual peroxisome proliferator-activated receptor alpha/delta agonist.
Jin L; Lin S; Rong H; Zheng S; Jin S; Wang R; Li Y
J Biol Chem; 2011 Sep; 286(36):31473-9. PubMed ID: 21775429
[TBL] [Abstract][Full Text] [Related]
58. Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice.
Costantini V; Fuschiotti P; Giampietri A; Allegrucci M; Agnelli G; Nenci GG; Fioretti MC
Prostaglandins; 1990 Jun; 39(6):581-99. PubMed ID: 1695382
[TBL] [Abstract][Full Text] [Related]
59. Expression profile and role of prostacyclin receptor (PTGIR) in peri-implantation porcine conceptuses.
Morawska-Pucinska E; Szymanska M; Blitek A
Theriogenology; 2014 Sep; 82(4):546-56. PubMed ID: 24954635
[TBL] [Abstract][Full Text] [Related]
60. Prostacyclin is an endosteal bone marrow niche component and its clinical analog iloprost protects hematopoietic stem cell potential during stress.
Tay J; Barbier V; Helwani FM; Price GR; Levesque JP; Winkler IG
Stem Cells; 2021 Nov; 39(11):1532-1545. PubMed ID: 34260805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
